Please download the dossier by clicking on the dossier button x
×

Modulation of apolipoprotein C-III expression

  • US 20040208856A1
  • Filed: 04/16/2003
  • Published: 10/21/2004
  • Est. Priority Date: 04/16/2003
  • Status: Active Grant
First Claim
Patent Images

1. A compound 8 to 80 nucleobases in length targeted to a nucleic acid molecule encoding apolipoprotein C-III, wherein said compound specifically hybridizes with said nucleic acid molecule encoding apolipoprotein C-III (SEQ ID NO:

  • 4) and inhibits the expression of apolipoprotein C-III.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×